Do "reverse payment" settlements constitute an anticompetitive pay-for-delay?
Year of publication: |
2015
|
---|---|
Authors: | Drake, Keith M. ; Starr-McCluer, Martha ; McGuire, Thomas G. |
Published in: |
International journal of the economics of business. - Abingdon, Oxfordshire : Routledge, ISSN 1357-1516, ZDB-ID 1196953-2. - Vol. 22.2015, 2, p. 173-200
|
Subject: | Pharmaceuticals | Antitrust | Reverse Payment | Event Studies | Patent Settlements | Zahlungsverkehr | Payment transactions | Pharmaindustrie | Pharmaceutical industry | Patent | Wettbewerbspolitik | Competition policy | Kartellrecht | Antitrust law | Ereignisstudie | Event study | Theorie | Theory | Patentrecht | Patent law | Arzneimittel | Internationaler Zahlungsverkehr | International payments |
-
Event study analysis in cases with multiple brand-generic reverse-payment settlements
Hartman, Raymond S., (2019)
-
Delayed entry settlements at the patent office
Hovenkamp, Erik, (2018)
-
Optimal incentives for patent challenges in the pharmaceutical industry
Böhme, Enrico, (2021)
- More ...
-
Drake, Keith M., (2014)
-
Drake, Keith M., (2014)
-
No free launch : at-risk entry by generic drug firms
Drake, Keith M., (2022)
- More ...